| Continuous versus intermittent β-lactam infusion in severe sepsis. A meta-analysis of individual patient data from randomized trials JA Roberts, MH Abdul-Aziz, JS Davis, JM Dulhunty, MO Cotta, J Myburgh, ... American journal of respiratory and critical care medicine 194 (6), 681-691, 2016 | 209 | 2016 |
| A systematic review of the definitions, determinants, and clinical outcomes of antimicrobial de-escalation in the intensive care unit A Tabah, MO Cotta, J Garnacho-Montero, J Schouten, JA Roberts, ... Clinical infectious diseases 62 (8), 1009-1017, 2016 | 125 | 2016 |
| The ADMIN-ICU survey: a survey on antimicrobial dosing and monitoring in ICUs A Tabah, J De Waele, J Lipman, JR Zahar, MO Cotta, G Barton, JF Timsit, ... Journal of Antimicrobial Chemotherapy 70 (9), 2671-2677, 2015 | 65 | 2015 |
| Measuring antimicrobial prescribing quality in Australian hospitals: development and evaluation of a national antimicrobial prescribing survey tool R James, L Upjohn, M Cotta, S Luu, C Marshall, K Buising, K Thursky Journal of Antimicrobial Chemotherapy 70 (6), 1912-1918, 2015 | 50 | 2015 |
| Attitudes towards antimicrobial stewardship: results from a large private hospital in Australia MO Cotta, MS Robertson, M Tacey, C Marshall, KA Thursky, D Liew, ... Healthcare infection 19 (3), 89-94, 2014 | 49 | 2014 |
| Antibiotic dose optimization in critically ill patients MO Cotta, JA Roberts, J Lipman Medicina intensiva 39 (9), 563-572, 2015 | 35 | 2015 |
| Antimicrobial stewardship in Victorian hospitals: a statewide survey to identify current gaps RS James, KA McIntosh, SB Luu, MO Cotta, C Marshall, KA Thursky, ... Medical Journal of Australia 199 (10), 692-695, 2013 | 34 | 2013 |
| Antimicrobial stewardship in Australian hospitals and other settings KA Cairns, JA Roberts, MO Cotta, AC Cheng Infectious diseases and therapy 4 (1), 27-38, 2015 | 30 | 2015 |
| Using periodic point‐prevalence surveys to assess appropriateness of antimicrobial prescribing in A ustralian private hospitals MO Cotta, MS Robertson, LM Upjohn, C Marshall, D Liew, KL Buising Internal medicine journal 44 (3), 240-246, 2014 | 30 | 2014 |
| Is high-dose β-lactam therapy associated with excessive drug toxicity in critically ill patients? C Mcdonald, MO Cotta, PJ Little, B Mcwhinney, JP Ungerer, J Lipman, ... Minerva anestesiologica 82 (9), 957-965, 2016 | 23 | 2016 |
| Implementing antimicrobial stewardship in the Australian private hospital system: a qualitative study MO Cotta, MS Robertson, C Marshall, KA Thursky, D Liew, KL Buising Australian Health Review 39 (3), 315-322, 2015 | 22 | 2015 |
| A protocol for a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis: BLING III J Lipman, SJ Brett, J De Waele, MO Cotta, JS Davis, S Finfer, P Glass, ... Critical Care and Resuscitation, 2019 | 15 | 2019 |
| Working Group for Antimicrobial Use in the ICU within the Infection Section of the European Society of Intensive Care Medicine (ESICM). The ADMIN-ICU survey: a survey on … A Tabah, J De Waele, J Lipman, JR Zahar, MO Cotta, G Barton, JF Timsit, ... J Antimicrob Chemother 70 (9), 2671-7, 2015 | 14 | 2015 |
| The use and risks of antibiotics in critically ill patients KJ Denny, MO Cotta, SL Parker, JA Roberts, J Lipman Expert opinion on drug safety 15 (5), 667-678, 2016 | 13 | 2016 |
| Antimicrobial stewardship of β-lactams in intensive care units MO Cotta, JA Roberts, A Tabah, J Lipman, D Vogelaers, S Blot Expert review of anti-infective therapy 12 (5), 581-595, 2014 | 13 | 2014 |
| Impact of renal replacement modalities on the clearance of piperacillin-tazobactam administered via continuous infusion in critically ill patients C Roger, MO Cotta, L Muller, SC Wallis, J Lipman, JY Lefrant, JA Roberts International journal of antimicrobial agents 50 (2), 227-231, 2017 | 12 | 2017 |
| Antibiotic exposure at the site of infection: principles and assessment of tissue penetration NGL Jager, RM van Hest, J Lipman, JA Roberts, MO Cotta Expert review of clinical pharmacology 12 (7), 623-634, 2019 | 11 | 2019 |
| Does critical illness change levofloxacin pharmacokinetics? JA Roberts, MO Cotta, P Cojutti, M Lugano, G Della Rocca, F Pea Antimicrobial agents and chemotherapy 60 (3), 1459-1463, 2016 | 11 | 2016 |
| Should β-lactam antibiotics be administered by continuous infusion in critically ill patients? A survey of Australia and New Zealand intensive care unit doctors and pharmacists MO Cotta, JM Dulhunty, JA Roberts, J Myburgh, J Lipman International journal of antimicrobial agents 47 (6), 436-438, 2016 | 10 | 2016 |
| We need to optimize piperacillin-tazobactam dosing in critically ill patients—but how? MO Cotta, JA Roberts, J Lipman Critical Care 20 (1), 1-3, 2016 | 9 | 2016 |
